Publication Name	World Journal of Virology
Manuscript ID	103347
Country	India

Received	2024-11-18 13:28
Peer-Review Started	2024-11-18 13:28
To Make the First Decision
Return for Revision	2025-03-21 06:28
Revised	2025-05-01 17:14
Second Decision	2025-07-11 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-07-11 05:53
Articles in Press	2025-07-11 05:53
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-07-25 07:44
Typeset the Manuscript	2025-09-10 07:23
Publish the Manuscript Online	2025-09-25 09:22

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Chronic hepatitis B: Is it time for expanded antiviral treatment?
Manuscript Source	Invited Manuscript
All Author List	Manish Manrai, Atul A Jha, Aditya V Pachisia and Saurabh Dawra
ORCID	Author(s) ORCID Number Manish Manrai http://orcid.org/0000-0002-5805-033X Atul A Jha http://orcid.org/0000-0002-2850-8397 Aditya V Pachisia http://orcid.org/0009-0005-1787-6257 Saurabh Dawra http://orcid.org/0000-0002-7679-9491
Funding Agency and Grant Number
Corresponding Author	Manish Manrai, Professor, Department of Gastroenterology, Command Hospital, Lucknow-226002, Lucknow 226002, Uttar Pradesh, India. manishmanrai75@gmail.com
Key Words	Chronic hepatitis B; Hepatocellular carcinoma; Hepatitis B treatment guidelines; Occult B infection; Immune tolerant phase; Expanded treatment for hepatitis B
Core Tip	An estimated 254 million people, almost 3.3% of the world's population, are estimated to be living with chronic hepatitis B (CHB) infection. Without therapy, they are at risk of developing cirrhosis and might develop hepatocellular cancer (HCC). The prevention of HCC is a major challenge. We review the various clinical practice guidelines and consider emerging evidence that will foster research to consider the expansion of treatment indications of CHB.
Publish Date	2025-09-25 09:22
Citation	<p>Manrai M, Jha AA, Pachisia AV, Dawra S. Chronic hepatitis B: Is it time for expanded antiviral treatment? <i>World J Virol</i> 2025; 14(3): 103347</p>
URL	https://www.wjgnet.com/2220-3249/full/v14/i3/103347.htm
DOI	https://dx.doi.org/10.5501/wjv.v14.i3.103347

Full Article (PDF)	WJV-14-103347-with-cover.pdf
Manuscript File	103347_Auto_Edited-YJP-Language__ editing-Webster J-Clear.docx
Answering Reviewers	103347-answering-reviewers.pdf
Audio Core Tip	103347-audio.m4a
Conflict-of-Interest Disclosure Form	103347-conflict-of-interest-statement.pdf
Copyright License Agreement	103347-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	103347-non-native-speakers.pdf
Peer-review Report	103347-peer-reviews.pdf
Scientific Misconduct Check	103347-scientific-misconduct-check.png
Scientific Editor Work List	103347-scientific-editor-work-list.pdf
CrossCheck Report	103347-crosscheck-report.pdf